Shawn Murphy

Mr. Shawn Murphy

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2026 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Open access
JWJacob Francis Wood
Jacob Francis Wood
MRMadhu Vishnu Sankar Reddy Rami Reddy
Madhu Vishnu Sankar Reddy Rami Reddy
SMShawn Murphy
Shawn Murphy
TDTarak Davuluri
Tarak Davuluri
AHAlastair Hoyt
Alastair Hoyt
Introduction: Chronic back pain is a leading cause of disability worldwide, contributing to reduced productivity and diminished quality of life for many patients. Spine surgery, particularly lumbar decompression and fusion, serves as an intensive intervention after conservative measures fail. Despite advances in surgical technique and instrumentation, outcomes remain highly variable, with up to half of patients experiencing little or no meaningful improvement. This variability has prompted growing interest in predictive models that forecast which patients are most likely to benefit from surgery. Methods: This review examines the current landscape of predictive modeling for patient-reported outcomes (PROs) in spine surgery. We evaluated the use of PRO instruments, which have become central to assessing surgical success. We further explored existing predictive models that incorporate demographic, clinical, and psychosocial variables, as well as emerging applications of artificial intelligence (AI) and machine-learning techniques aimed at improving diagnostic accuracy and prognostic performance. Results: Current predictive models demonstrate variable performance across populations and remain constrained by incomplete datasets, inconsistencies in definitions, and limited integration of psychosocial factors. While most models report moderate discrimination for categorical outcomes (AUC 0.62–0.84), the subjective nature of PROs and the complexity of postoperative recovery pose challenges to accurate prediction. Machine-learning approaches, including neural networks, show promise in identifying complex relationships among diverse predictors of surgical outcomes. Future advancements will rely on leveraging multimodal data sources and integrating them through AI-driven frameworks. Transparency and external validation remain essential for clinical implementation. Conclusion: While PROs remain essential for understanding patient experiences and benchmarking surgical success, they often fall short as standalone predictive tools. The next generation of modeling should integrate multidimensional data and utilize AI’s capacity to detect clinically meaningful patterns. When implemented, these models have the potential to enhance preoperative counseling, guide surgical decision-making, and advance personalized spine care.

22 October 2026 in Current Biology
Verified
Journal Article
Closed access
CCChristian T. Candler
Christian T. Candler
GPGabrielle A. Peña
Gabrielle A. Peña
IWIsabelle F. Witteveen
Isabelle F. Witteveen
SMShawn Murphy
Shawn Murphy
KWKennedy E. Whittaker
Kennedy E. Whittaker
TBTimothy S. Balmer
Timothy S. Balmer

24 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MRMadhu Vishnu Sankar Reddy Rami Reddy
Madhu Vishnu Sankar Reddy Rami Reddy
JWJacob Francis Wood
Jacob Francis Wood
JNJordan Nicole Norris
Jordan Nicole Norris
KBKathryn Becker
Kathryn Becker
SMShawn Murphy
Shawn Murphy
Robert SmithRobert Smith
Robert Smith
Background: Emerging evidence suggests that biological sex shapes glioma biology and therapeutic response. Methods: We performed a sex-stratified analysis of CGGA (Chinese Glioma Genome Atlas) RNA sequencing data comparing low-grade glioma (LGG) with high-grade glioma (HGG) and glioblastoma (GBM). Using the 3PodR framework, we integrated differential expression analysis with Gene Set Enrichment Analysis (GSEA), EnrichR, leading-edge analysis, and iLINCS drug repurposing. Results: These comparisons provide a proxy for biological processes underlying malignant transformation. In LGG vs. HGG, 973 significantly differentially expressed genes (DEGs) were identified in females and 1236 in males, with 15.5% and 33.5% unique to each sex, respectively. In LGG vs. GBM, 2011 DEGs were identified in females and 2537 in males, with 12.6% and 30.7% being unique. Gene-level contrasts included GLI1 upregulation in males and downregulation in females, GCGR upregulation in males, MYOD1 upregulation in females, and HIST1H2BH downregulation in males. Additional top DEGs included PRLHR, DGKK, DNMBP-AS1, HOXA9, CTB-1I21.1, RP11-47I22.1, HPSE2, SAA1, DLK1, H19, PLA2G2A, and PI3. In both sexes, LGG–HGG and LGG–GBM grade comparisons converged on neuronal and synaptic programs, with enrichment of glutamatergic receptor genes and postsynaptic modules, including GRIN2B, GRIN2A, GRIN2C, GRIN1, and CHRNA7. In contrast, collateral pathways diverged by sex: females showed downregulation of mitotic and chromosome-segregation programs, whereas males showed reduction of extracellular matrix and immune-interaction pathways. Perturbagen analysis nominated signature-reversing compounds across sexes, including histone deacetylase inhibitors, Aurora kinase inhibitors, microtubule-targeting agents such as vindesine, and multi-kinase inhibitors targeting VEGFR, PDGFR, FLT3, PI3K, and MTOR. Conclusions: Glioma grade comparisons reveal a shared neuronal–synaptic program accompanied by sex-specific transcriptional remodeling. These findings support sex-aware therapeutic strategies that pair modulation of neuron–glioma coupling with chromatin- or receptor tyrosine kinase/angiogenic-targeted agents, and they nominate biomarkers such as GLI1, MYOD1, GCGR, PRLHR, and HIST1H2BH for near-term validation.